BARD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.626000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.226400E-01
Normal-vs-Stage2
7.595600E-01
Normal-vs-Stage3
1.182380E-01
Normal-vs-Stage4
5.962600E-01
Stage1-vs-Stage2
8.027000E-01
Stage1-vs-Stage3
1.337220E-01
Stage1-vs-Stage4
2.999400E-01
Stage2-vs-Stage3
4.378100E-02
Stage2-vs-Stage4
1.114410E-01
Stage3-vs-Stage4
1.191750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.380800E-01
Normal-vs-AfricanAmerican
9.327600E-01
Normal-vs-Asian
8.358000E-01
Caucasian-vs-AfricanAmerican
4.046200E-01
Caucasian-vs-Asian
7.233800E-01
AfricanAmerican-vs-Asian
7.004000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.658800E-01
Normal-vs-Female
6.711800E-01
Male-vs-Female
7.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.030400E-01
Normal-vs-Age(41-60Yrs)
8.385000E-01
Normal-vs-Age(61-80Yrs)
6.471200E-01
Normal-vs-Age(81-100Yrs)
3.322200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.276600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.215600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.313000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.518400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.121220E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.712200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.577600E-01
Normal-vs-Daily Drinker
3.951400E-01
Normal-vs-Weekly Drinker
9.952400E-01
Normal-vs-Occasional Drinker
8.177800E-01
Normal-vs-Social Drinker
6.594600E-01
Non Drinker-vs-Daily Drinker
3.862400E-01
Non Drinker-vs-Weekly Drinker
4.812200E-01
Non Drinker-vs-Occasional Drinker
5.793800E-01
Non Drinker-vs-Social Drinker
7.837000E-01
Daily Drinker-vs-Weekly Drinker
2.048000E-01
Daily Drinker-vs-Occasional Drinker
2.484000E-01
Daily Drinker-vs-Social Drinker
3.393400E-01
Weekly Drinker-vs-Occasional Drinker
7.405600E-01
Weekly Drinker-vs-Social Drinker
6.061200E-01
Occasional Drinker-vs-Social Drinker
8.031000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
6.083900E-03
Grade 1-vs-Grade 3
2.382600E-03
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
6.006400E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.212600E-01
Normal-vs-NonDiabetic
5.739400E-01
Diabetic-vs-NonDiabetic
7.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.333000E-01
Normal-vs-NoPancreatitis
5.767600E-01
Pancreatitis-vs-NoPancreatitis
6.621600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.013600E-01
Normal-vs-N1
7.590000E-01
N0-vs-N1
1.868240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.483600E-01
Normal-vs-TP53-NonMutant
7.496600E-01
TP53-Mutant-vs-TP53-NonMutant
8.402600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
